BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 16711019)

  • 1. Clinical implications of promoter hypermethylation in RASSF1A and MGMT in retinoblastoma.
    Choy KW; Lee TC; Cheung KF; Fan DS; Lo KW; Beaverson KL; Abramson DH; Lam DS; Yu CB; Pang CP
    Neoplasia; 2005 Mar; 7(3):200-6. PubMed ID: 15799820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of O6-methylguanine-DNA methyltransferase in human lung adenocarcinoma relates to high-grade histology and worse prognosis among smokers.
    Hayashi H; Yazawa T; Okudela K; Nagai J; Ito T; Kanisawa M; Kitamura H
    Jpn J Cancer Res; 2002 Feb; 93(2):184-9. PubMed ID: 11856482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian inference supports a location and neighbour-dependent model of DNA methylation propagation at the MGMT gene promoter in lung tumours.
    Bonello N; Sampson J; Burn J; Wilson IJ; McGrown G; Margison GP; Thorncroft M; Crossbie P; Povey AC; Santibanez-Koref M; Walters K
    J Theor Biol; 2013 Nov; 336():87-95. PubMed ID: 23911575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of DNA methylation in head and neck cancer.
    Demokan S; Dalay N
    Clin Epigenetics; 2011 Aug; 2(2):123-50. PubMed ID: 22704334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter hypermethylation patterns of P16, DAPK and MGMT in oral squamous cell carcinoma: a systematic review and meta-analysis.
    Don KR; Ramani P; Ramshankar V; Sherlin HJ; Premkumar P; Natesan A
    Indian J Dent Res; 2014; 25(6):797-805. PubMed ID: 25728117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MGMT hypermethylation: a prognostic foe, a predictive friend.
    Jacinto FV; Esteller M
    DNA Repair (Amst); 2007 Aug; 6(8):1155-60. PubMed ID: 17482895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter hypermethylation of DNA repair gene MGMT in laryngeal squamous cell carcinoma.
    Zhang S; Guo C; Kong W; Liu Z
    J Huazhong Univ Sci Technolog Med Sci; 2006; 26(1):101-4. PubMed ID: 16711019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Promoter hypermethylation of DNA repair gene O6-methylguanine DNA methyltransferase in laryngeal squamous cell carcinoma].
    Zhang S; Kong WJ; Liu Z
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Mar; 39(3):152-6. PubMed ID: 15283294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relation to p53 mutations in esophageal squamous cell carcinoma.
    Zhang L; Lu W; Miao X; Xing D; Tan W; Lin D
    Carcinogenesis; 2003 Jun; 24(6):1039-44. PubMed ID: 12807758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter hypermethylation and inactivation of O(6)-methylguanine-DNA methyltransferase in esophageal squamous cell carcinomas and its reactivation in cell lines.
    Fang MZ; Jin Z; Wang Y; Liao J; Yang GY; Wang LD; Yang CS
    Int J Oncol; 2005 Mar; 26(3):615-22. PubMed ID: 15703815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia.
    Esteller M; Hamilton SR; Burger PC; Baylin SB; Herman JG
    Cancer Res; 1999 Feb; 59(4):793-7. PubMed ID: 10029064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant promoter hypermethylation of p16 and MGMT genes in oral squamous cell carcinomas and the surrounding normal mucosa.
    Kato K; Hara A; Kuno T; Mori H; Yamashita T; Toida M; Shibata T
    J Cancer Res Clin Oncol; 2006 Nov; 132(11):735-43. PubMed ID: 16791592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
    Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
    Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. O(6)-Methylguanine-DNA methyltransferase promoter hypermethylation shifts the p53 mutational spectrum in non-small cell lung cancer.
    Wolf P; Hu YC; Doffek K; Sidransky D; Ahrendt SA
    Cancer Res; 2001 Nov; 61(22):8113-7. PubMed ID: 11719438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between methylating and pyridyloxobutylating agents in A/J mouse lungs: implications for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis.
    Peterson LA; Thomson NM; Crankshaw DL; Donaldson EE; Kenney PJ
    Cancer Res; 2001 Aug; 61(15):5757-63. PubMed ID: 11479212
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.